Report Publication Announcement • Mar 21, 2024
Report Publication Announcement
Open in ViewerOpens in native device viewer
CORRECTION: Aker BioMarine ASA – Annual Report 2023 ESEF
21 March 2024: Aker BioMarine ASA has published its annual financial statements in European
Single Electronic Format (ESEF), available as an attachment to this release.
Correction: New version enclosed due to an incorrect file name of
the file containing the annual financial statements in European Single
Electronic Format (ESEF) published yesterday at 08:00 CET.
For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: [email protected]
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.